In line with this, it has been reported that the expression levels of GLUT1 and hexokinase-2 are substantially upregulated in high-grade serous ovarian carcinoma compared to non-high-grade serous ovarian carcinoma, and the GLUT1 expression level is higher in advanced ovarian cancer stages compared with early ones. Here, SLC2A1 is linked to ovarian cancer.